GLP-1s Are Showing Promise Beyond Weight Loss. Could They Be ‘Wonder Drugs’ for Ailments Like Addiction, Dementia and Cancer?
Matt MillerZiyad Al-Aly, MD, has led multiple studies on long COVID-19 as a clinical epidemiologist at Washington University School of Medicine in St. Louis and the Veterans Affairs St. Louis Health Care system. His latest findings show that people who have been infected with COVID-19 are at an increased risk of developing a range of gastrointestinal conditions within the first month to a year after illness.
Source: Smithsonian Magazine